Tigermed Reports Share Buyback Totaling 20.96 Million Shares

Deep News
07/02

Hangzhou Tigermed Consulting Co.,Ltd. (ASX: 300347) has announced the completion of a significant share repurchase initiative.

According to a company filing, as of June 30, 2026, the firm had repurchased a total of 20,963,478 of its own shares through a dedicated securities account using centralized bidding transactions.

This repurchased volume represents 2.4347% of the company's current total issued share capital and accounts for 2.8410% of its total A-share capital.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10